Severe Valvular Regurgitation: An Unexpected Complication During Transapical Aortic Valve Implantation Treated Successfully with the “Valve-in-Valve” Procedure

Year 2012, , 444 - 446, 01.04.2012

Ethem Kavukcu Kamil Mehmet Burgazlı Rıdvan Chasan Ethem Kavukçu Mehmet Bilgin Ali Erdoğan

https://doi.org/10.5152/balkanmedj.2012.040

Abstract

Severe symptomatic aortic stenosis (AS) in a multimorbid 77 year old female was treated with transapical aortic valve implantation with a 23 mm Edwards Sapien valve. Severe valvular regurgitation following implantation, probably due to structural valve failure, was treated successfully with a second valve-in- valve implantation. During a follow-up time of 2,5 years no further problems occurred.

Keywords

TAVI, aortic regurgitation, complication

Severe Valvular Regurgitation: An Unexpected Complication During Transapical Aortic Valve Implantation Treated Successfully with the “Valve-in-Valve” Procedure

Abstract

References

• Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high risk patients with aortic stenosis. Circulation 2007;116:755-63. [CrossRef]
• Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116:240-5. [CrossRef]
• Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case descrip- tion. Circulation 2002;106:3006-8. [CrossRef]
• Ducrocq G, Francis F, Serfaty JM, Himbert D, Maury JM, Pasi N, et al. Vascular complications of transfemoral aortic valve implan- tation with the Edwards SAPIEN prosthesis: incidence and im- pact on outcome. EuroIntervention 2010;5:666-72. [CrossRef]
• Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schul- tz C, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic Core Valve System: the Rot- terdam experience. EuroIntervention 2010;5:673-9. [CrossRef]
• Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Mar- tin P, et al. Atrioventricular block after transcatheter balloon ex- pand- able aortic valve implantation. JACC Cardiovasc Interv 2008;1:305-9. [CrossRef]
• Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009;2:811-20. [CrossRef]
• Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, et al. Percutaneous aortic valve replacement for severe aortic ste- nosis in high-risk patients using the second- and current third-gener- ation self-expanding CoreValve prosthesis: device success and 30- day clinical outcome. J Am Coll Cardiol 2007;50:69-76. [CrossRef]
• Rodes-Cabau J, Dumont E, Doyle D. Valve in valve for the treat- ment of paravalvular leaks following transcatheter aortic valve im- plantation. Catheter Cardiovasc Interv 2009;74:1116-9. [CrossRef]
• Sherif MA, Abdel-Wahab M, Stöcker B, Geist V, Richardt D, Tölg R, et al. Anatomic and procedural predictors of paravalvular aor- tic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 2010;56:1623-9. [CrossRef]
• Al-Attar N, Ghodbane W, Himbert D, Rau C, Raffoul R, Messika- zeitoun D, et al. Unexpected complications of transapical aortic valve implantation. Ann Thorac Surg 2009;88:90-4. [CrossRef]
• Schaff HV. Transcatheter aortic-valve implantation--at what price? N Engl J Med 2011;364:2256-8. Balkan Med J 2012; 29: 444-6
• Severe Valvular Regurgitation